Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
about
Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.Lighting up tumors with receptor-specific optical molecular probes.Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.Cancer treatment using peptides: current therapies and future prospectsBombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cellsCurrent and emerging molecular targets in glioma.Targeting GRPR in urological cancers--from basic research to clinical application.Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.
P2860
Q28238324-7F8F87B8-168D-4165-8AA3-C5061529C382Q33956262-E864EA3E-3DBD-4F60-B505-72DB864E56D8Q34330174-9B472787-5142-4909-A6DD-AC617ABE3F4AQ35843526-756ADF87-6AF0-45EE-8F55-38339A4B29CBQ36276948-B6A000A3-2A96-4758-B1F2-9235B92BD030Q36515785-FDA2D14B-6649-442C-AC7E-C41E8CB6C5F6Q36673732-92EF9C5D-7664-4EB5-930C-42D79CA976DAQ37641064-C92B1726-A4AE-4C5A-B044-515292BE0D0DQ37809861-EFAEEF23-5444-4B10-9AAD-6977D0EAE7F4Q38090926-31A445EC-CB62-4DF1-AB0F-F21724953939Q41842236-E52F8319-11D8-45B3-A1C4-C2AE9FC542F6Q47964670-DB218247-2EAF-4984-8765-02B3DC84D017
P2860
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@ast
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@en
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@nl
type
label
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@ast
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@en
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@nl
prefLabel
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@ast
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@en
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@nl
P2093
P2860
P356
P1476
Bombesin antagonists inhibit g ...... and c-jun and c-fos oncogenes.
@en
P2093
Ana M Bajo
Francine Hebert
Kate Groot
Magdalena Krupa
P2860
P304
P356
10.1073/PNAS.052715299
P407
P577
2002-03-12T00:00:00Z